ClinicalTrials.Veeva

Menu
North America Research Institute | NARI San Dimas, CA - Other PI's logo

North America Research Institute | NARI San Dimas, CA - Other PI's

Research site

Site insights

Top conditions

Top treatments

Apricoxib
Gemcitabine
MK-2060
Capecitabine
Calcifediol
SNF472
Clazakizumab
PA101B
Erlotinib
Lapatinib

Parent organization

This site is a part of North America Research Institute

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Molly Way

Verified by this site

Active trials

2 of 13 total trials

Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)

The purpose of this study is to evaluate the efficacy and safety of two different doses of MK-2060 (a monoclonal antibody against Factor XI) in end s...

Active, not recruiting
End-Stage Renal Disease
End-Stage Kidney Disease
Drug: MK-2060
Drug: Placebo

The overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week...

Enrolling
CDI
C.Difficile Diarrhea
Biological: Placebo
Biological: VE303

Trial sponsors

T
Boehringer Ingelheim logo
CSL Behring logo
C
I
Merck Sharp & Dohme (MSD) logo
OPKO Health logo
P
Sandoz logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems